A revolutionary, universal stem cell platform for muscle regeneration
Myogenica is a biotechnology company spun out of the University of Minnesota developing MyoPAXon, a universal induced pluripotent stem cell (iPSC) platform for muscle regeneration. The MyoPAXon platform leverages PAX7 expression — found exclusively in muscle stem cells — to regenerate muscle and improve function in multiple forms of muscular dystrophy, including Duchenne, limb girdle, and facioscapulohumeral muscular dystrophy (FSHD).
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
